10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$1.35B
Close$
$42.06
286.2% upside
Current Fair Value
286.2% upsideUndervalued by 286.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.35 Billion |
|---|---|
| Enterprise Value | $1.08 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.52 |
| Beta | 1.98 |
| Outstanding Shares | 122,606,091 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.44 |
|---|---|
| PEG | 19.77 |
| Price to Sales | 2.18 |
| Price to Book Ratio | 2.18 |
| Enterprise Value to Revenue | 1.73 |
| Enterprise Value to EBIT | -5.96 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov